Essex Woodlands Health Ventures as of March 31, 2014
Portfolio Holdings for Essex Woodlands Health Ventures
Essex Woodlands Health Ventures holds 11 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revance Therapeutics (RVNC) | 36.8 | $145M | 4.6M | 31.50 | |
| D Horizon Pharma | 21.6 | $85M | 5.8M | 14.62 | |
| Abiomed | 20.9 | $82M | 3.2M | 26.04 | |
| Endologix | 13.1 | $52M | 1.2M | 44.23 | |
| Acura Pharmaceuticals | 3.6 | $14M | 10M | 1.39 | |
| ZIOPHARM Oncology | 3.0 | $12M | 2.8M | 4.27 | |
| MediciNova (MNOV) | 0.6 | $2.4M | 1.2M | 2.05 | |
| Curis | 0.2 | $659k | 234k | 2.82 | |
| CHINA CORD Blood Corp | 0.1 | $347k | 87k | 4.00 | |
| Palatin Technologies | 0.0 | $29k | 24k | 1.21 | |
| Echo Therapeutics | 0.0 | $37k | 12k | 3.00 |
